IL148543A0 - Pharmaceutical carrier formulation - Google Patents

Pharmaceutical carrier formulation

Info

Publication number
IL148543A0
IL148543A0 IL14854300A IL14854300A IL148543A0 IL 148543 A0 IL148543 A0 IL 148543A0 IL 14854300 A IL14854300 A IL 14854300A IL 14854300 A IL14854300 A IL 14854300A IL 148543 A0 IL148543 A0 IL 148543A0
Authority
IL
Israel
Prior art keywords
pharmaceutical carrier
carrier formulation
formulation
pharmaceutical
carrier
Prior art date
Application number
IL14854300A
Other languages
English (en)
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of IL148543A0 publication Critical patent/IL148543A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL14854300A 1999-09-27 2000-09-26 Pharmaceutical carrier formulation IL148543A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40616499A 1999-09-27 1999-09-27
PCT/US2000/026381 WO2001022942A1 (en) 1999-09-27 2000-09-26 Pharmaceutical carrier formulation

Publications (1)

Publication Number Publication Date
IL148543A0 true IL148543A0 (en) 2002-09-12

Family

ID=23606801

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14854300A IL148543A0 (en) 1999-09-27 2000-09-26 Pharmaceutical carrier formulation

Country Status (18)

Country Link
EP (1) EP1216029A1 (zh)
JP (1) JP2003510267A (zh)
KR (1) KR20020064289A (zh)
CN (1) CN1399542A (zh)
AR (1) AR025867A1 (zh)
AU (1) AU7716100A (zh)
BR (1) BR0014308A (zh)
CA (1) CA2388471A1 (zh)
CZ (1) CZ20021082A3 (zh)
EA (1) EA200200415A1 (zh)
HK (1) HK1044485A1 (zh)
HU (1) HUP0202652A3 (zh)
IL (1) IL148543A0 (zh)
MX (1) MXPA02003190A (zh)
NO (1) NO20021476L (zh)
PL (1) PL354331A1 (zh)
WO (1) WO2001022942A1 (zh)
ZA (1) ZA200203311B (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7138393B2 (en) 1998-07-24 2006-11-21 Wyeth Biologically active vasopressin agonist metabolites
US20030105144A1 (en) * 2001-04-17 2003-06-05 Ping Gao Stabilized oral pharmaceutical composition
JPWO2004073692A1 (ja) * 2003-02-18 2006-06-01 山下 伸二 難水溶性薬物のハードカプセル剤
CN100342856C (zh) * 2003-04-10 2007-10-17 上海医药工业研究院 达那唑半固体骨架制剂的组合物
JP5406529B2 (ja) 2005-10-26 2014-02-05 バナー ファーマキャプス, インコーポレイテッド カプセル充墳物としての親油性ベヒクルに基づく二重制御された放出マトリクスシステム
CN101360485B (zh) * 2005-10-26 2013-04-17 班纳制药公司 作为胶囊填充物的基于亲水性载体的双重控释基质系统
US20100093725A1 (en) * 2006-10-31 2010-04-15 Wyeth Semi-solid formulations of phospholipase enzyme inhibitors
JP7268012B2 (ja) * 2017-12-20 2023-05-02 フイルメニツヒ ソシエテ アノニム 口腔ケア組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3636123A1 (de) * 1986-10-23 1988-05-05 Rentschler Arzneimittel Arzneizubereitungen zur oralen verabreichung, die als einzeldosis 10 bis 240 mg dihydropyridin enthalten
US5599808A (en) * 1994-02-18 1997-02-04 Cephalon, Inc. Aqueous indolocarbazole solutions
ATE429210T1 (de) * 1998-01-20 2009-05-15 Applied Analytical Ind Inc Orale flüssige zusammensetzungen

Also Published As

Publication number Publication date
MXPA02003190A (es) 2002-09-30
CA2388471A1 (en) 2001-04-05
EA200200415A1 (ru) 2002-10-31
BR0014308A (pt) 2002-05-21
HK1044485A1 (zh) 2002-10-25
NO20021476D0 (no) 2002-03-25
KR20020064289A (ko) 2002-08-07
HUP0202652A2 (hu) 2004-05-28
JP2003510267A (ja) 2003-03-18
CN1399542A (zh) 2003-02-26
AU7716100A (en) 2001-04-30
WO2001022942A1 (en) 2001-04-05
PL354331A1 (en) 2004-01-12
NO20021476L (no) 2002-04-16
EP1216029A1 (en) 2002-06-26
HUP0202652A3 (en) 2004-06-28
ZA200203311B (en) 2003-12-31
AR025867A1 (es) 2002-12-18
CZ20021082A3 (cs) 2002-06-12

Similar Documents

Publication Publication Date Title
EG24226A (en) Formulation
GB9905898D0 (en) Controlled-dose formulation
GB9902304D0 (en) Formulation
HK1045102A1 (zh) 藥物配方
IL148543A0 (en) Pharmaceutical carrier formulation
GB9915231D0 (en) Pharmaceutical complex
GB9909154D0 (en) Pharmaceutical formulation
GB9927614D0 (en) Sterliant formulation
GB9926251D0 (en) Pharmaceutical formulation
GB9906126D0 (en) Pharmaceutical formulations
GB9930578D0 (en) Pharmaceutical formulations
GB9817470D0 (en) Pharmaceutical formulation
GB9802617D0 (en) Pharmaceutical formulation
GB9910633D0 (en) Pharmaceutical formulation
GB9922187D0 (en) Pharmaceutical formulation
GB9921396D0 (en) Pharmaceutical formulation
GB9930700D0 (en) Pharmaceutical formulation
GB9927685D0 (en) Pharmaceutical formulation
GB9930878D0 (en) Pharmaceutical formulation
GB9910636D0 (en) Pharmaceutical formulation
GB9919840D0 (en) Pharmaceutical formulation
GB9917777D0 (en) Pharmaceutical formulation
GB9917772D0 (en) Pharmaceutical formulation
GB9917774D0 (en) Pharmaceutical formulation
GB9917775D0 (en) Pharmaceutical formulation